Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
neurostimulation
MedTech
Acquisitive Boston Scientific sees growth rate ease in Q3
Boston Scientific’s third-quarter revenue topped $5 billion, up 20.3% year over year.
Ben Adams
Oct 22, 2025 10:05am
Boston Scientific to drop $533M to acquire Nalu Medical
Oct 20, 2025 12:04pm
MicroTransponder nets $65M for stroke rehab neurostimulator
Mar 14, 2025 12:53pm
Inspire Medical discloses DOJ civil false claims investigation
Feb 11, 2025 3:00pm
Cala raises $50M to boost its wearable hand tremor therapy
Dec 9, 2024 10:58am
FDA amplifies Inspire's sleep apnea nerve stimulator recall
Jul 9, 2024 12:00pm